Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)

<p><strong>Background:</strong> Treatment Resistant Bipolar Depression (TRBD) is a major contributor to the burden of disease associated with Bipolar Disorder (BD). Treatment options for people experiencing bipolar depression are limited to three interventions listed by National In...

Full description

Bibliographic Details
Main Authors:	Azim, L, Hindmarch, P, Browne, G, Chadwick, T, Clare, E, Courtney, P, Dixon, L, Duffelen, N, Fouweather, T, Geddes, JR, Goudie, N, Harvey, S, Helter, T, Holstein, E-M, Martin, G, Mawson, P, McCaffery, J, Morriss, R, Simon, J, Smith, D, Stokes, PRA, Walker, J, Weetman, C, Wolstenhulme, F, Young, AH, Watson, S, McAllister-Williams, RH
Format:	Journal article
Language:	English
Published:	BioMed Central 2021

Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study)

Similar Items